Navigation Links
Bivalirudin, a new anti-clotting drug may be a safer option for treatment of acute coronary conditions

A novel anti-clotting drug named bivalirudin is turning out to be a better option than combination drug therapy for patients suffering heightened //coronary conditions, for instance heart attacks.

Lead researcher Dr. Gregg W. Stone, a professor of medicine and director of cardiovascular research and education at Columbia University said, "We use it at Columbia in the vast majority of cases. We find that compared to heparin, it is just as effective and safely allows us to do angioplasty with a major reduction in bleeding episodes."

During a study involving 14,000 patients, who had suffered heart attack or other acute coronary syndromes, study participants were administered either a treatment including heparin, or a package including bivalirudin or just bivalirudin.It was found that Bivalrudin reduced the occurrence of artery blockage or severe bleeding by nearly 14 percent compared to the effects of a drug package that included Heparin.

"It makes care of patients in the cath lab much simpler and safer. The big difference was the reduction of major bleeding, almost 50 percent. Major bleeding has been associated with higher mortality, so it is important for the outcome", Dr. Gregg W. Stone said.

Dr. John A. Bittl, an interventional cardiologist at the Munroe Regional Medical Center in Ocala, commented, "This report states that bivalirudin can be used for patents with acute coronary syndrome with a lower risk of bleeding than conventional treatment."
'"/>




Page: 1

Related medicine news :

1. Enduring anti-clotting treatment avails heart patients
2. Useful device makes spinal surgery safer
3. Transporter offers reliable clues for safer pain medicine
4. Arthritis drugs safer than previously declared
5. Diet and exercise can be a better option to control diabetes
6. Early detection of alcohol abuse is better option for treatment
7. Children obesity has an option in the form of surgery
8. Substituting soymilk for lactose intolerant students n schools: a great option
9. To cope better with HRT, a good option is Hysterectomies
10. Sweet nothings: A fruitful option to assuage the sweet tooth
11. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
Post Your Comments:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
... to determine and help patients to have a recurren...chemotherapy drugs docetaxel (Taxotere) and vinore...es.// It was previously reported by the Finnish r...fusions of trastuzumab (Herceptin) were less likel...
...nfocomm, which helped SARS affected South-East Asi...thermal scanners are now under the process of desi...is of the bird flu and isolate people affected by ...sion from the central and state government by send...
... delivery even if not needed they should be asked ...ugh the experts at Royal College of Midwives (RCM)...g number of women asking for the injection. About ...idural, which costs about ?500 in a private matern...
...in its sordid journey. Tracing its beginnings, res... involvement in the development of cancer. // It w...may hold clues for lasting remedy of the diseased ...th every tumor, there are abnormal stem cells that...
Other Medicine News:Health News:Trails to detect effective breast cancer drugs that reduces recurrences 2
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- Prometheus...pany, today announced findings from its,developmen...nly blood test,for irritable bowel syndrome (IBS)....e expression of particular biomarkers in blood sam...ication of these biomarkers,combined with a propr...
(Date:10/7/2008)... Results of FLEXX Trial Presented at the Oste...orld Congress, PARSIPPANY, N.J., Oct. 7 /PRNewswi...nted results from the FLEXX Trial of Osteoarthriti... hyaluronate), a highly pure,non-avian high molecu...,(IA-HA), is superior to intra-articular saline (I...
(Date:10/7/2008)... In a clinical study of adults, VYVANSE taken... ADHD within one week, PHILADELPHIA, Oct. 7 /PRNe...SHPGY), the global specialty biopharmaceutical com...e September issue of the Journal of,Clinical Psych...ved,Attention Deficit Hyperactivity Disorder (ADHD...
(Date:10/7/2008)... BERKELEY, Calif., Oct. 7 /- Aer...d safety data from a Phase I trial of its Aerovant...ity with no evidence of,local irritancy following ...., This 10 mg dose will be the highest of three d...nging study, which is scheduled to begin early,nex...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2US Based Bollywood On Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd 3600 1US Based Bollywood On Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd 3600 2US Based Bollywood On Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd 3600 3National healthcare advocate from Harvard Med School to speak at NJIT 3596 1Sunday October 14 MSPP holds Sixth Annual Lucero Memorial Run and Latino Leadership Breakfast 3592 1Sunday October 14 MSPP holds Sixth Annual Lucero Memorial Run and Latino Leadership Breakfast 3592 2Inconsistencies with Neanderthal genomic DNA sequences 786 1
...ws Promise As an Adjuvant for Vaccines,against Avi...7, 2007 /PRNewswire-FirstCall/ -- IR,BioSciences H...a,from its influenza vaccine adjuvant study being ...es Homspera elevates host,immune responsiveness ab...sults are from an ongoing study, and are a strong,...
...7, 2007 /PRNewswire-FirstCall/ --,Citing issues re...g,of paclitaxel, Conor Medsystems, LLC has conclud...Antiproliferative for Restenosis),trial, the pivot...-eluting coronary stent, failed to meet its primar...es, and the overall,rates of death, myocardial inf...
Other Medicine Technology:IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 2IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 3IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 4Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 2Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 3Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 4
...th EnCap technology is used for cardiac and great ...losure. It is glutaraldehyde-treated bovine perica...ty, plus improved suturability and handling over s...tch product is the ability to prevent calcificatio...
Unique triaxial catheter design and ergonomic handle for easy and accurate deployment. Six proprietary radiopaque Nitinol markers on the proximal and distal ends of the stent enhance visibility. Corr
Supreme and Response catheters comprise the world's broadest line of fixed-curve catheters available for electrophysiology procedures. Their advanced catheter design and materials technology provide
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety.
Medicine Products: